Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

Clinical Infectious Diseases

Volumn 59, Issue 8, 2014, Pages 1066-1073

  Harboe, Zitta Barrella ^a,b   Dalby, Tine ^a   Weinberger, Daniel M ^c   Benfield, Thomas ^d,e,f   Mølbak, Kåre ^a   Slotved, Hans Christian ^a   Suppli, Camilla H ^a   Konradsen, Helle Bossen ^a   Valentiner Branth, Palle ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

^c YALE UNIVERSITY   (United States)

^d Department of Infectious Diseases ^*  (United States)

^e Mental Health Services CPH   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Incidence; Indirect effect; IPD; Mortality; Pneumococcal conjugate vaccination

Indexed keywords

PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DANISH CITIZEN; DRUG EFFICACY; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MIDDLE AGED; MORBIDITY; MORTALITY; MORTALITY RATE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; YOUNG ADULT; BACTEREMIA; CLASSIFICATION; DENMARK; FEMALE; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MENINGITIS, BACTERIAL; PNEUMOCOCCAL INFECTIONS; SEROTYPING; SURVIVAL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84922531773     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu524     Document Type: Article

References (28)

1. Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis 2013; 19:61-8.
2. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41.
3. Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 2010; 28:2642-7.
4. Statens Serum Institut. PCV7 coverage and invasive pneumococcal disease 2011. [in Danish]. EPI-NEWS week 21, 2012. Available at: http:// www.ssi.dk/English/News/EPI-NEWS/2012/No%2021%20-%202012. aspx. Accessed 7 April 2014.
5. Calbo E, Garau J. Invasive pneumococcal disease in children: changing serotypes and clinical expression of disease. Clin Infect Dis 2005; 41:1821-2.
6. Kyaw MH, Rose CE Jr, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005; 192:377-86.
7. Rosen JB, Thomas AR, Lexau CA, et al. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 2011; 53:137-43.
8. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 2011; 29:9127-31.
9. Kaplan SL, Barson WJ, Lin PL, et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2013; 32:203-7.
10. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346-54.
11. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009; 6:e1000081.
12. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011; 2:e00309-310.
13. Soneji S, Metlay J. Mortality reductions for older adults differ by race/ ethnicity and gender since the introduction of adult and pediatric pneu-mococcal vaccines. Public Health Rep 2011; 126:259-69.
14. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53:441-9.
15. Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005. Vaccine 2008; 26: 3765-71.
16. Kaltoft MS, Skov Sorensen UB, Slotved HC, Konradsen HB. An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J Microbiol Methods 2008; 75:540-4.
17. Lambertsen L, Kerrn MB. Test of a novel Streptococcus pneumoniae se-rotype 6C type specific polyclonal antiserum (factor antiserum 6d) and characterisation of serotype 6C isolates in Denmark. BMC Infect Dis 2010; 10:282.
18. Statens Serum Institut. Pneumococcal vaccine in the Danish childhood vaccination programme [in Danish] 2009. EPI-NEWS No. 38, 2008. Available at: http://www.ssi.dk/sw58939.asp. Accessed 7 April 2014.
19. Harboe ZB, Benfield TL, Valentiner-Branth P, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 2010; 50:329-37.
20. Ingels H, Rasmussen J, Andersen PH, et al. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme. Vaccine 2012; 30: 3944-50.
21. Statens Serum Institut. PCV7 coverage & invasive pneumococcal disease 2010. [in Danish]. Statens Serum Institut, 2011. EPI-NEWS week 19, 2011. Available at: http://www.ssi.dk/English/News/EPI-NEWS/2011/No%2019%20-%202011.aspx. Accessed 7 April 2014.
22. Farrington CP, Andrews NJ, Beale AD, Catchpole MA. A statistical algorithm for the early detection of outbreaks of infectious disease. J R Stat Soc A Stat 1996; 159:547-63.
23. Core Team (2012). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. Available at: http://www.R-project.org/. Accessed 7 April 2014.
24. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008; 197:1016-27.
25. Steens A, Bergsaker MA, Aaberge IS, Ronning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococ-cal disease in Norway. Vaccine 2013; 31:6232-8.
26. Statens Serum Institut . Pneumococcal vaccination of persons at increased risk of invasive pneumococcal disease. [in Danish]. 2014. EPI-NEWS, week 51B, 2012. Available at: http://www.ssi.dk/English/ News/EPI-NEWS/2012/No%2051b%20-%202012.aspx. Accessed 7 April 2014.
27. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51:692-9.
28. Weinberger DM, Harboe ZB, Viboud C, et al. Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia. J Infect Dis 2013; 208:1274-80.